DELTEX MEDICAL GROUP PLC

Share Issue/Capital Change • Dec 23, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2475W

Deltex Medical Group PLC

23 December 2013

Deltex Medical Group plc

Directors' Shareholdings/Issue of equity

23 December 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 790,574 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 14.00 pence per share.

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 October 2012 to 31 December 2013.

Paul Mitchell, Finance Director has elected to take New Ordinary Shares in lieu of £20,000 of salary in respect of the period 1 January 2013 to 31 December 2013.

In addition to the above, the Company also announces that it has today issued a total of 71,429 New Ordinary Shares to a former employee of the Company at a price of 14.00 pence per share in settlement of contractual obligations.

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 31 December 2013.  Following the issue of these new shares the Company has a total of 168,070,379  ordinary shares of 1p each in issue.

Following this issue, the directors' beneficial interests are as follows:

Name of Director	Number of New Ordinary Shares issued in lieu of fees/salary	Holding of shares following issue of New Ordinary Shares	% of enlarged issued share capital
Nigel Keen	297,616	6,985,163	4.16
Dr Edwin Snape	214,286	1,430,624	0.85
Sir Duncan Nichol	75,000	928,916	0.55
Julian Cazalet	49,386	4,080,268	2.43
Paul Mitchell	82,857	352,831	0.21

For further information:

Deltex Medical Group plc	01243 774 837 investorinfo@deltexmedical.com
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Paul Mitchell, Finance Director
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie
Financial Public Relations
Newgate Threadneedle	020 7653 9850
Graham Herring
Caroline Evans-Jones
Heather Armstrong

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCFEIFDDFDSEDE